Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (2196.HK)
HKD 13.76
(-1.57%)
HKD 13.76
(-1.57%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 113.46 Billion CNY | 5.88% |
| 2022 | 107.16 Billion CNY | 14.87% |
| 2021 | 93.29 Billion CNY | 11.48% |
| 2020 | 83.68 Billion CNY | 9.94% |
| 2019 | 76.11 Billion CNY | 7.89% |
| 2018 | 70.55 Billion CNY | 13.85% |
| 2017 | 61.97 Billion CNY | 41.59% |
| 2016 | 43.76 Billion CNY | 14.57% |
| 2015 | 38.2 Billion CNY | 8.11% |
| 2014 | 35.33 Billion CNY | 19.88% |
| 2013 | 29.47 Billion CNY | 15.56% |
| 2012 | 25.5 Billion CNY | 14.43% |
| 2011 | 22.29 Billion CNY | 32.52% |
| 2010 | 16.82 Billion CNY | 45.92% |
| 2009 | 11.52 Billion CNY | 52.9% |
| 2008 | 7.53 Billion CNY | 1.4% |
| 2007 | 7.43 Billion CNY | 12.08% |
| 2006 | 6.63 Billion CNY | 17.03% |
| 2005 | 5.66 Billion CNY | 9.64% |
| 2004 | 5.17 Billion CNY | 22.56% |
| 2003 | 4.21 Billion CNY | 34.38% |
| 2002 | 3.13 Billion CNY | 42.23% |
| 2001 | 2.2 Billion CNY | 40.5% |
| 2000 | 1.57 Billion CNY | 83.06% |
| 1999 | 858.23 Million CNY | 32.62% |
| 1998 | 647.13 Million CNY | 125.38% |
| 1997 | 287.13 Million CNY | 158.0% |
| 1996 | 111.29 Million CNY | 4.31% |
| 1995 | 106.69 Million CNY | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 113.74 Billion CNY | 0.24% |
| 2024 Q3 | 115.26 Billion CNY | -0.24% |
| 2024 Q2 | 115.53 Billion CNY | 1.58% |
| 2023 Q1 | 107.37 Billion CNY | 0.2% |
| 2023 Q2 | 112.14 Billion CNY | 4.44% |
| 2023 Q3 | 110.76 Billion CNY | -1.23% |
| 2023 Q4 | 113.46 Billion CNY | 2.44% |
| 2023 FY | 113.46 Billion CNY | 5.88% |
| 2022 Q1 | 95.77 Billion CNY | 2.66% |
| 2022 FY | 107.16 Billion CNY | 14.87% |
| 2022 Q4 | 107.16 Billion CNY | 2.72% |
| 2022 Q3 | 104.32 Billion CNY | 5.59% |
| 2022 Q2 | 98.8 Billion CNY | 3.16% |
| 2021 Q3 | 90.3 Billion CNY | 2.06% |
| 2021 Q4 | 93.29 Billion CNY | 3.31% |
| 2021 FY | 93.29 Billion CNY | 11.48% |
| 2021 Q1 | 86.61 Billion CNY | 3.5% |
| 2021 Q2 | 88.47 Billion CNY | 2.15% |
| 2020 Q1 | 77.59 Billion CNY | 1.93% |
| 2020 FY | 83.68 Billion CNY | 9.94% |
| 2020 Q2 | 80.16 Billion CNY | 3.32% |
| 2020 Q3 | 80.54 Billion CNY | 0.47% |
| 2020 Q4 | 83.68 Billion CNY | 3.9% |
| 2019 FY | 76.11 Billion CNY | 7.89% |
| 2019 Q1 | 72.75 Billion CNY | 3.12% |
| 2019 Q2 | 73.68 Billion CNY | 1.29% |
| 2019 Q3 | 78.56 Billion CNY | 6.62% |
| 2019 Q4 | 76.11 Billion CNY | -3.12% |
| 2018 Q3 | 68.51 Billion CNY | 3.49% |
| 2018 FY | 70.55 Billion CNY | 13.85% |
| 2018 Q2 | 66.19 Billion CNY | 3.9% |
| 2018 Q4 | 70.55 Billion CNY | 2.98% |
| 2018 Q1 | 63.71 Billion CNY | 2.82% |
| 2017 Q4 | 61.97 Billion CNY | 9.7% |
| 2017 FY | 61.97 Billion CNY | 41.59% |
| 2017 Q3 | 56.49 Billion CNY | 11.57% |
| 2017 Q2 | 50.63 Billion CNY | 6.96% |
| 2017 Q1 | 47.33 Billion CNY | 8.16% |
| 2016 Q2 | 40.94 Billion CNY | 3.35% |
| 2016 Q4 | 43.76 Billion CNY | 3.61% |
| 2016 FY | 43.76 Billion CNY | 14.57% |
| 2016 Q3 | 42.24 Billion CNY | 3.18% |
| 2016 Q1 | 39.61 Billion CNY | 3.71% |
| 2015 Q4 | 38.2 Billion CNY | 2.1% |
| 2015 Q2 | 36.34 Billion CNY | 2.67% |
| 2015 FY | 38.2 Billion CNY | 8.11% |
| 2015 Q3 | 37.41 Billion CNY | 2.94% |
| 2015 Q1 | 35.4 Billion CNY | 0.18% |
| 2014 Q2 | 31.04 Billion CNY | 3.31% |
| 2014 Q1 | 30.05 Billion CNY | 1.96% |
| 2014 Q4 | 35.33 Billion CNY | 6.31% |
| 2014 FY | 35.33 Billion CNY | 19.88% |
| 2014 Q3 | 33.23 Billion CNY | 7.06% |
| 2013 FY | 29.47 Billion CNY | 15.56% |
| 2013 Q4 | 29.47 Billion CNY | 6.83% |
| 2013 Q3 | 27.58 Billion CNY | -0.05% |
| 2013 Q2 | 27.6 Billion CNY | 6.49% |
| 2013 Q1 | 25.91 Billion CNY | 1.62% |
| 2012 Q4 | 25.5 Billion CNY | 13.85% |
| 2012 FY | 25.5 Billion CNY | 14.43% |
| 2012 Q1 | 22.24 Billion CNY | -0.22% |
| 2012 Q2 | 22.32 Billion CNY | 0.36% |
| 2012 Q3 | 22.4 Billion CNY | 0.37% |
| 2011 Q4 | 22.29 Billion CNY | 6.28% |
| 2011 Q1 | 19.51 Billion CNY | 16.03% |
| 2011 Q2 | 19.43 Billion CNY | -0.43% |
| 2011 FY | 22.29 Billion CNY | 32.52% |
| 2011 Q3 | 20.97 Billion CNY | 7.93% |
| 2010 FY | 16.82 Billion CNY | 45.92% |
| 2010 Q1 | 12.11 Billion CNY | 5.13% |
| 2010 Q3 | 14.4 Billion CNY | 7.55% |
| 2010 Q4 | 16.82 Billion CNY | 16.73% |
| 2010 Q2 | 13.39 Billion CNY | 10.55% |
| 2009 Q1 | 8.23 Billion CNY | 9.29% |
| 2009 Q4 | 11.52 Billion CNY | 5.01% |
| 2009 Q3 | 10.97 Billion CNY | 27.29% |
| 2009 FY | 11.52 Billion CNY | 52.9% |
| 2009 Q2 | 8.62 Billion CNY | 4.66% |
| 2008 Q3 | 7.15 Billion CNY | -2.07% |
| 2008 Q4 | 7.53 Billion CNY | 5.35% |
| 2008 Q1 | 7.32 Billion CNY | -1.48% |
| 2008 FY | 7.53 Billion CNY | 1.4% |
| 2008 Q2 | 7.3 Billion CNY | -0.24% |
| 2007 Q3 | 6.64 Billion CNY | -1.78% |
| 2007 Q2 | 6.76 Billion CNY | 0.98% |
| 2007 FY | 7.43 Billion CNY | 12.08% |
| 2007 Q1 | 6.69 Billion CNY | 0.96% |
| 2007 Q4 | 7.43 Billion CNY | 11.92% |
| 2006 Q2 | 6.07 Billion CNY | 4.71% |
| 2006 Q4 | 6.63 Billion CNY | 5.32% |
| 2006 Q3 | 6.29 Billion CNY | 3.65% |
| 2006 Q1 | 5.8 Billion CNY | 2.38% |
| 2006 FY | 6.63 Billion CNY | 17.03% |
| 2005 Q3 | 5.65 Billion CNY | 2.46% |
| 2005 Q4 | 5.66 Billion CNY | 0.19% |
| 2005 Q1 | 5.5 Billion CNY | 6.47% |
| 2005 Q2 | 5.52 Billion CNY | 0.31% |
| 2005 FY | 5.66 Billion CNY | 9.64% |
| 2004 Q3 | 5.05 Billion CNY | 1.6% |
| 2004 Q1 | 4.34 Billion CNY | 3.08% |
| 2004 Q2 | 4.97 Billion CNY | 14.44% |
| 2004 FY | 5.17 Billion CNY | 22.56% |
| 2004 Q4 | 5.17 Billion CNY | 2.25% |
| 2003 Q3 | 3.45 Billion CNY | -2.2% |
| 2003 Q1 | 3.13 Billion CNY | -0.05% |
| 2003 Q4 | 4.21 Billion CNY | 22.24% |
| 2003 Q2 | 3.52 Billion CNY | 12.46% |
| 2003 FY | 4.21 Billion CNY | 34.38% |
| 2002 Q1 | 2.48 Billion CNY | 12.61% |
| 2002 FY | 3.13 Billion CNY | 42.23% |
| 2002 Q3 | 2.65 Billion CNY | -7.42% |
| 2002 Q2 | 2.87 Billion CNY | 15.55% |
| 2002 Q4 | 3.13 Billion CNY | 18.07% |
| 2001 Q4 | 2.2 Billion CNY | 0.0% |
| 2001 FY | 2.2 Billion CNY | 40.5% |
| 2001 Q2 | 1.74 Billion CNY | 0.0% |
| 2000 FY | 1.57 Billion CNY | 83.06% |
| 2000 Q2 | 1.26 Billion CNY | 0.0% |
| 2000 Q4 | 1.57 Billion CNY | 0.0% |
| 1999 Q2 | 764.58 Million CNY | 0.0% |
| 1999 Q4 | 858.23 Million CNY | 0.0% |
| 1999 FY | 858.23 Million CNY | 32.62% |
| 1998 FY | 647.13 Million CNY | 125.38% |
| 1998 Q4 | 647.13 Million CNY | 0.0% |
| 1998 Q2 | 168.27 Million CNY | 0.0% |
| 1997 FY | 287.13 Million CNY | 158.0% |
| 1996 FY | 111.29 Million CNY | 4.31% |
| 1995 FY | 106.69 Million CNY | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Pak Fah Yeow International Limited | 907.46 Million HKD | -12404.02% |
| Grand Pharmaceutical Group Limited | 22.51 Billion HKD | -403.966% |
| Extrawell Pharmaceutical Holdings Limited | 1.28 Billion HKD | -8715.303% |
| Wai Yuen Tong Medicine Holdings Limited | 2.09 Billion HKD | -5315.926% |
| Qianhai Health Holdings Limited | 478.11 Million HKD | -23632.602% |
| Lee's Pharmaceutical Holdings Limited | 2.89 Billion HKD | -3825.378% |
| Essex Bio-Technology Limited | 2.82 Billion HKD | -3912.989% |
| Tongfang Kontafarma Holdings Limited | 1.72 Billion HKD | -6469.056% |
| PuraPharm Corporation Limited | 843.96 Million HKD | -13344.855% |
| SSY Group Limited | 11.96 Billion HKD | -848.24% |
| JBM (Healthcare) Limited | 1.38 Billion HKD | -8070.94% |
| Jacobson Pharma Corporation Limited | 3.48 Billion HKD | -3154.212% |
| China Resources Pharmaceutical Group Limited | 271.69 Billion HKD | 58.236% |